Relmada Therapeutics Inc (STU:4E2)
€ 2.98 0.26 (9.56%) Market Cap: 89.48 Mil Enterprise Value: 25.50 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 34/100

Relmada Therapeutics Inc (STU:4E2) Transcripts

  • 1